Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Zoono Group Limited ( (AU:ZNO) ).
Zoono Group Limited has concluded its non-renounceable rights issue, raising approximately $785,005.55, with a significant portion of shares subscribed by the Managing Director, Paul Hyslop. The funds will support projects like supermarket shelf-life extension, expansion into China and India, debt repayment, and intellectual property protection. The remaining shares will be offered in a Shortfall Offer, open for three months, to further bolster the company’s financial position and strategic initiatives.
More about Zoono Group Limited
Zoono Group Limited is a global biotech company that specializes in developing, manufacturing, and distributing environmentally-friendly antimicrobial solutions. Their product range includes sprays, wipes, and foams for skin care, surface sanitization, and mould remediation, all based on a unique antimicrobial molecule. Headquartered in New Zealand, Zoono’s products are available worldwide and have received various regulatory approvals supported by independent testing.
Average Trading Volume: 603,072
Technical Sentiment Signal: Sell
Current Market Cap: A$11.37M
Find detailed analytics on ZNO stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money